Back
22nd Century Group Vs. Immunovant Industry Stock Comparison
Sell
31
XXII
22nd Century Group
Last Price:
0.24
Seasonality Move:
40.3%
Buy
88
IMVT
Immunovant
Last Price:
40.83
Seasonality Move:
-5.87%
Sell
31
22nd Century Group (XXII)
is a Sell
Is 22nd Century Group a Buy, Sell or Hold?
- The current 22nd Century Group [XXII] share price is $0.24. The Score for XXII is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- XXII is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
88
Immunovant (IMVT)
is a Buy
Is Immunovant a Buy, Sell or Hold?
- The current Immunovant [IMVT] share price is $40.81. The Score for IMVT is 88, which is 76% above its historic median score of 50, and infers lower risk than normal.
- IMVT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
XXII Stock Price Chart
What is 22nd Century Group's stock price today?
-
The 22nd Century Group share price today is $0.24
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XXII is experiencing slight selling pressure.
IMVT Stock Price Chart
What is Immunovant's stock price today?
-
The Immunovant share price today is $40.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMVT is experiencing buying pressure, which is a positive indicator for future bullish movement.
XXII Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 32.04 | Sell |
Chaikin Money Flow: | -1214060 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.25 - 0.43) | Sell |
Bollinger Bands (100): | (0.29 - 2.45) | Sell |
IMVT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.54 | Buy |
Relative Strength Index (14 RSI): | 73 | Buy |
Chaikin Money Flow: | 1550727 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.07 - 36.97) | Buy |
Bollinger Bands (100): | (21.43 - 35.49) | Buy |
XXII Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.24 | Sell |
20-day SMA: | 0.31 | Sell |
50-day SMA: | 0.5 | Sell |
200-day SMA: | 5.6 | Sell |
8-day EMA: | 0.25 | Sell |
20-day EMA: | 0.32 | Sell |
50-day EMA: | 0.69 | Sell |
200-day EMA: | 5.65 | Sell |
IMVT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.79 | Buy |
20-day SMA: | 34.82 | Buy |
50-day SMA: | 35.08 | Buy |
200-day SMA: | 23.25 | Buy |
8-day EMA: | 37.77 | Buy |
20-day EMA: | 35.75 | Buy |
50-day EMA: | 33.32 | Buy |
200-day EMA: | 24.9 | Buy |
22nd Century Group Earnings Growth & XXII Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.79 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and an increase next year of $3.44 per share.
Immunovant Earnings Growth & IMVT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.22 per share.
22nd Century Group Technical Analysis
Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | Dec 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
20 | 21 | 22 | 24 | 27 | 28 | 29 | 30 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Immunovant Technical Analysis
Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | Dec 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
20 | 21 | 22 | 24 | 27 | 28 | 29 | 30 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |